![Stanley Iyadurai](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Stanley Iyadurai worked as Director-Neuromuscular Genetics Clinic at The Ohio State University.
From 2017 to 2018, worked as Director-Clinical Research & Development at CSL Behring LLC.
From 2018 to 2025, worked as Senior VP-Medical Affairs & Drug Discovery at Catalyst Pharmaceuticals, Inc. Education includes a doctorate from the University of Minnesota.
Anciens postes connus de Stanley Iyadurai
| Sociétés | Poste | Fin |
|---|---|---|
| CATALYST PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | 02/12/2025 |
CSL Behring LLC
 CSL Behring LLC BiotechnologyHealth Technology Manufactures and markets plasma protein products | Corporate Officer/Principal | 01/07/2018 |
The Ohio State University
 The Ohio State University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Formation de Stanley Iyadurai
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
10
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Catalyst Pharmaceuticals, Inc.
 Catalyst Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets novel medicines for patients living with rare diseases | Health Technology |
The Ohio State University
The Ohio State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Minnesota
 University of Minnesota Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CSL Behring LLC
CSL Behring LLC BiotechnologyHealth Technology Manufactures and markets plasma protein products | Health Technology |
